Biotechnology Companies, June 2013

You might be interested in: protein, stem cell, cell therapy, more »

» Read our Company Profiles

About 100 Companies

Johnson and Johnson

United States

GlaxoSmithKline P.L.C.

United States

Biogen Idec

United States

Merck KGaA

Germany

Life Technologies Corp.

United States

Abbott Laboratories

United States

Novartis Inc.

Switzerland

Nutrition Co.

United States

Celgene Corp.

United States

Pfizer Inc.

United States

StemCells Inc.

United States

Amgen Inc.

United States

Illumina Inc.

United States

Genzyme Corp.

United States

GlaxoSmithKline PLC

United Kingdom

Bioheart Inc.

United States

Aastrom Biosciences Inc.

United States

Eli Lilly and Co.

United States

Cephalon Inc.

United States

454 Life Sciences

United States

Affymetrix Inc.

United States

Osiris Therapeutics Inc.

United States

AstraZeneca PLC

United Kingdom

Geron Corp.

United States

» Download Public Reports

About 6 300 reports
Company Report: Protein in The United States for Year 2013

Company Report: Protein in The United States for Year 2013

  • Company report
  • May 2013
  • 11 pages

... Therapeutics for folding diseases or folding solutions are difficult to develop because proteins are moving targets }disease or misfolding n o ye s -high throughput readout signal -- yes/no decrease ...


» Purchase Premium Reports (From $ 75 - $ 7 438)

About 2 600 reports
Analytical Tool - Antibodies and Peptides in Oncology

Analytical Tool - Antibodies and Peptides in Oncology

  • $ 8 925
  • Industry report
  • April 2013
  • by Bioseeker

"Analytical Tool - Antibodies and Peptides in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and ...

U.s. Qpcr Reagents Market

April 2013 $ 6 000

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.